USD 0.5
(2.04%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | 8.35 Million USD | 53.55% |
2023 | 5.44 Million USD | 19.08% |
2022 | 4.57 Million USD | 259.08% |
2021 | 1.27 Million USD | 162.0% |
2020 | 485.77 Thousand USD | 711.45% |
2019 | 59.86 Thousand USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 FY | 8.35 Million USD | 53.55% |
2024 Q1 | 1.91 Million USD | 24.89% |
2024 Q3 | 2.16 Million USD | 8.44% |
2024 Q4 | 2.27 Million USD | 4.81% |
2024 Q2 | 1.99 Million USD | 4.31% |
2023 Q3 | 1.4 Million USD | 9.51% |
2023 Q2 | 1.28 Million USD | 4.5% |
2023 FY | 5.44 Million USD | 19.08% |
2023 Q1 | 1.22 Million USD | -14.96% |
2023 Q4 | 1.53 Million USD | 9.47% |
2022 Q4 | 1.44 Million USD | 74.66% |
2022 Q3 | 824.83 Thousand USD | -27.3% |
2022 Q2 | 1.13 Million USD | -3.03% |
2022 Q1 | 1.17 Million USD | 168.16% |
2022 FY | 4.57 Million USD | 259.08% |
2021 Q1 | 250.55 Thousand USD | 810.45% |
2021 FY | 1.27 Million USD | 162.0% |
2021 Q2 | 135.28 Thousand USD | -46.0% |
2021 Q3 | 141.88 Thousand USD | 4.88% |
2021 Q4 | 436.34 Thousand USD | 207.52% |
2020 Q2 | 231.69 Thousand USD | 31.33% |
2020 Q3 | 281.11 Thousand USD | 21.33% |
2020 FY | 485.77 Thousand USD | 711.45% |
2020 Q1 | 176.41 Thousand USD | 1169.35% |
2020 Q4 | -35.26 Thousand USD | -112.55% |
2019 Q1 | 17.66 Thousand USD | 0.0% |
2019 FY | 59.86 Thousand USD | 0.0% |
2019 Q3 | 90.13 Thousand USD | 139.46% |
2019 Q2 | 37.64 Thousand USD | 113.15% |
2019 Q4 | 13.89 Thousand USD | -84.58% |
2018 Q1 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2014 FY | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Acutus Medical, Inc. | -3.13 Million USD | 366.378% |
Cell MedX Corp. | - USD | -Infinity% |
Dynatronics Corporation | 7.63 Million USD | -9.447% |
Nemaura Medical Inc. | -1.47 Million USD | 665.993% |
PetVivo Holdings, Inc. | 739.52 Thousand USD | -1029.951% |
RetinalGenix Technologies Inc. | -100.00 USD | 8356381.0% |
Sonendo, Inc. | 10.72 Million USD | 22.064% |
Telesis Bio, Inc. | 16.95 Million USD | 50.7% |
Talis Biomedical Corporation | 371 Thousand USD | -2152.367% |
Viveve Medical, Inc. | 620 Thousand USD | -1247.787% |